Omega Metrix Ambulatorium Norwegian Fish Oil
Seznam literatury k náhlé zástavě srdce a srdečně – cévním onemocněním
  1. International Society for the Study of Fatty Acids and Lipids: Report of the Sub-Committee on RECOMMENDATIONS FOR INTAKE OF POLYUNSATURATED FATTY ACIDS IN HEALTHY ADULTS, June 2004,(PDF ke stažení, 453 KiB)
  2. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis. 2008;197:821-8
  3. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett, WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden cardiac death. N Engl J Med. 2002;346:1113-8
  4. Brouwer IA, Zock PL, Camm AJ, et al for the SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverters defibrillators. The Study on Omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial. J Am Med Assoc 2006;295:2613-2619
  5. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304
  6. Burr ML, Ashfield-Watt PAL, Dunstan FDJ, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trialt. Eur J Clin Nutr. 2003;57:193-200
  7. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. 1989. Effects of changes in fat, fish, and fibre intakes on death and myocardial infarction: diet and reinfarction trial (DART). Lancet 2:757-61
  8. Calo L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary bypass surgery. J Am Coll Cardiol. 2005;45:1723-8
  9. Cleland LG, James MJ, Proudman SM. The role of fish oil in the treatment of rheumatoid arthritis. Drugs 2003; 63:845-53
  10. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-1610
  11. Decsi T, Koletzko B. N-3 fatty acids and pregnancy outcomes. Curr Op Nutr Metab Care 2005; 8:161-6
  12. Donadio JV, Grande JP. IgA Nephropathy. N Engl J Med 2002; 347:738-48
  13. Engler MM, Engler MB, Malloy M, et al. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results form the EARLY study. Int J clin Pharmacol Ther 2004; 42:672-679
  14. Engler MM, Engler MB, Paul S, et al. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 2005; 95:869-871
  15. Gohlke H. Ernährung. Z Kardiol 2005; 94 Suppl 3: III/22-9
  16. Harris WS, von Schacky C.The Omega-3 index: A new risk factor for death from coronary heart disease ? Prev Med. 2004;39:212-20
  17. Holguin F, Tellez Rojo MM, Lazo M, et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest, 2005;127:1102-1107
  18. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of Omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Br Med J 2006;332:752-60
  19. Hu FB, Bronner L, Willett WC, Stamper MJ, Rexrode AM, Albert CM, Hunter D, Manson JE. Fish and Omega-3 fatty acid intake and risk of coronary heart disease in women. J Am Med Assoc 2002; 287:1815-21
  20. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345:1473-82
  21. Iso H, Kobayashi M, Ishihara J, et al, JPHC Study Group. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006;113:195-202
  22. JELIS, Lancet 2006, in press
  23. Kottke TE, Wu LA, Brekke LN, White RD. Preventing sudden death with n-3 (Omega-3) fatty acids and defibrillators. Am J Prev Med 2006; 31: 316-23
  24. Leaf A, Albert CM, Josephson M, et al for the Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005;112:2762-2768
  25. Lamotte M, Annemans L, Kawalec P, Zoellner Y. A multi-country health economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeocnomics 2006;24:783-795
  26. MacLean CH, Mojica WA, Newberry SJ, Pencharz J, Garland RH, Tu W, Hilton LG, Gralnek IM, Rhodes S, Kanna P, Morton SC. Systematic review of the effects of Omega-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 2005; 82: 611-9
  27. Marchioli R, Barzi F, Bomba E, et al. 2002. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell´Infarcto Miocardio (GISSI)-Prevenzione. Circulation, 105:1897-1903
  28. Moore MJ, Glover BM, McCann CJ, et al. Demographic and temporal trends in out of hospital sudden cardiac death in Belfast. Heart 2006;92:311-315
  29. Morgan DR, Dixon LJ, Hanratty CG, et al. Effects of dietary Omega-3 fatty acid supplementation on endothelium-dependent vasodilatation in patients with chronic heart failure. Am J Cardiol 2006; 97:547-551
  30. Mori TA, Woodman RJ. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Nutr Metab Care 2006; 9:95-104
  31. Morris MC Sacks F, Rosner B. Does fish oil lower blood pressure ? A meta-analysis of controlled trials. Circulation 1993; 88:523-533
  32. Mozaffarian D, Longstreth WT, Lemaitre RN, et al. Fish consumption and stroke risk in elderly individuals: the Cardiovascular Health Study. Arch Int Med 2005;165:200-206
  33. Mozaffarian D, Geelen A, Brouwer AI, et al. Effect of fish oil on heart rate in humans. A meta-analysis of randomized controlled trials. Circulation 2005;112:1946-1952
  34. Mozaffarian D, Prineas RJ, Stein PK, Siscovick DS. Dietary fish and n-3 fatty acid intake and cardiac electrographic parameters in humans. J Am Coll Cardiol 2006; 48:478-484
  35. Mozaffariann D, Rimm EB. Fish intake, contaminants, and human health. J Am Med Assoc 2006, 296:1885-99
  36. Mozaffarian D, Psaty B, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation 2004;110:368-373
  37. Ness AR, Ashfield-Watt PAL, Whiting JM, et al. The long-term effect of dietary advice on the diet of men with angina: the diet and angina randomized trial. J Hum Nutr Dietet. 2004;17:117-119
  38. Nishizawa H, Hamazaki K, Hamazaki T, et al. The relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In Vivo 2006;20:307-310
  39. O´Keefe JH jr, Abuissa H, Sastre A, et al. Effects of Omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejections fractions. Am J Cardiol 2006;97:1127-1130
  40. Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005; 65: 1051-9
  41. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. A randomized controlled trial. J Am Med Assoc 2005;293:2884-2891
  42. Rasmussen BM, Vessby B, Uusitupa M, et al. The KANWU Study Group. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr 2006; 83:221-226
  43. Reisman J, Schachter HM, Dales RE, Tran K, Kourad K, Barnes D, Sampson M, Morrison A, Gaboury E, Blackman J. Treating asthma with Omega-3 fatty acids: Where is the evidence ? A systematic review. BMC Complement Altern Med 2006; 6:26
  44. Saugstad LF. Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with dietary Omega-3 ? Nutr Health 2006; 18: 89-101
  45. Schmier JK, Rachman NJ, Halpern MT. The cost-effectiveness of Omega-3 supplements for prevention of secondary coronary events. Manag Care 2006;15:43-50
  46. Schrepf R, Limmer T, Weber PC, et al. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004;363:1441-1442
  47. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc. 1995; 275:836-7
  48. Smith SC, Allen J, Blair SN, et al. AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006;113:2363-2372
  49. Szajewska H, Horvath A, Koletzko B. Effect of long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006; 83:1337
  50. Tavazzi L, Tognoni G, Franzhosi MG, et al. GISSI-HF investigators. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur Heart J 2004; 6:635-641
  51. The GISSI Prevenzione Group. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet, 354:447-55. Erratum in: Lancet 2001;357:642
  52. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003;361:477-485
  53. Van der Werf F, Ardissino D, Betriu A, et al. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. 2003. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J.2003;24:28-66
  54. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr Opin Nutr Metab Care 2004; 7:131-136
  55. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary Omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind placebo-controlled trial. Ann Int Med 1999; 130:554-562
  56. von Schacky C, Harris WS. Cardiovascular benefits of Omega-3 fatty acids. Cardiovasc Res. 2006;http://dx.doi.org/10.1016/j.cardiores.2006.08.019
  57. von Schacky C, Harris WS, Mozaffarian D, Kris-Etherton PM (2006) Statement of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) www.ISSFAL.org.uk/HooperRebuttal.asp
  58. Virtanen JK, Voutilainen S, Rissanen TH, et al. Mercury, fish oils, and riks of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vas Biol 2005; 25:228-233
  59. Wang C, Harris WS, Chung M, et al. n-3 fatty acids from fish of fish oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006;84:5-17
  60. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary: a report of the American College of Cardiology / American Heart Association Task Force and the European Society for Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Eur Heart J 2006;27:2099-2140
Seznam literatury k těhotenství a kojení
  1. Bouwstra H, Dijck-Brouwer DAJ, Wildeman JAL, Tjoonk HM, van der Heide JC, Boersma ER, Muskiet FAJ, Hadders-Algra M. Long-chain polyunsaturated fatty acids have a positive effe on the quality of general movements of healthy term infants. Am J Clin Nutr 2003;78:313-8
  2. Dunstan JA, Mori TA, Barden A, Beilin LJ, Holt PG, Calder PC, Taylor AL, Prescott SL. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr. 2004;58:429-37
  3. Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment at 2 ½ years following fish oil supplementation in pregnancy: a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 2008;93:F45-50
  4. Harris WS, Connor WE, Lindsey S.Will dietary omega-3 fatty acids change the composition of human milk? Am J Clin Nutr. 1984;40:780-5
  5. Helland IB, Smith L, Saarem K, Saugsted OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age.Pediatrics 2003; 111:e39-44
  6. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002; 69:15
  7. Jayawant S, Rawlinson A, Gibbon F, Price J, Schulte J, Sharples P, Sibert JR, Kemp AM. Subdural haemorrhages in infants: population based study. BMJ. 1998;317:1558-61
  8. Jensen CL. Effect of n-3 fatty acids during pregnancy and lactation. Am J Clin Nutr 2006;83(Suppl)1452S-7S
  9. Koletzko B, Larqué E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J Perinat Med. 2007;35 Suppl 1:S5-11
  10. Koletzko B, Lien E, Agostoni C, Böhles H, Campoy C, Cetin I, Decsi T, Dudenhausen JW, Dupont C, Forsyth S, Hoesli I, Holzgreve W, Lapillonne A, Putet G, Secher NJ, Symonds M, Szajewska H, Willatts P, Uauy R. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36:5-14
  11. Larqué E, Krauss-Etschmann S, Campoy C, Hartl D, Linde J, Klingler M, Demmelmair H, Caño A, Gil A, Bondy B, Koletzko B Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr. 2006;84:853-61
  12. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 2006;3:CD003402
  13. Matsuzaka T, Yoshinaga M, Tsuji Y, Yasunaga A, Mori K.. Incidence and causes of intracranial hemorrhage in infancy: a prospective surveillance study after vitamin K prophylaxis. Brain Dev. 1989;11:384-8
  14. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. J Am Med Assoc. 2006;296:1885-99
  15. Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. Eur J Clin Nutr 2007;61:976-85
  16. Qiu C, Sanchez SE, Larrabure G, David R, Bralley JA, Williams MA. Erythrocyte omega-3 and omega-6 polyunsaturated fatty acids and preeclampsia risk in Peruvian women. Arch Gynecol Obstet. 2006;274:97-103
  17. Szajewaska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;83:1337-44
Seznam literatury k neurologii a psychiatrii
  1. Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2006;75:299-308
  2. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D, Ness AR. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr. 2006;84:1308-16.
  3. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63:1402-8
  4. Freeman MP, Hibbeln JR, Wisner KL et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006;1954-67
  5. Iso H, Sato S, Umemura U, Kudo M, Koike K, Kitamura A, Imano H, Okamura T, Naito Y, Shimamoto T. Linoleic acid, other fatty acids, and the risk of stroke. Stroke. 2002;33:2086-93
  6. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid ? Lipids in Health and Disease 2007; 6:21
  7. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63:1545-50
  8. Sontrop J, Campbell MK. w-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 2006; 42:4-13
  9. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry. 2006;163:1100-2
Seznam literatury k účinkům oleje z tresčích jater
  1. Aviram M, Brox J, Nordoy A. Acute effects of dietary cod liver oil and cream on plasma lipoproteins. Ann.Nutr Metab 1986;30:143-8.
  2. Brox JH, Killie JE, Gunnes S, Nordoy A. The effect of cod liver oil and corn oil on platelets and vessel wall in man. Thromb.Haemost. 1981;46:604-11.
  3. Brox JH, Killie JE, Osterud B, Holme S, Nordoy A. Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type IIa). Acta Med.Scand. 1983;213:137-44.
  4. Vognild E, Elvevoll EO, Brox J et al. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. Lipids 1998;33:427-36.
  5. Aviram M, Brox J, Nordoy A. Effects of postprandial plasma and chylomicrons on endothelial cells. Differences between dietary cream and cod liver oil. Acta Med.Scand. 1986;219:341-8.
  6. Brox J, Olaussen K, Osterud B et al. A long-term seal- and cod liver oil supplementation in hypercholesterolemic subjects. Lipids 2001;36:7-13.
  7. Skuladottir GV, Gudmundsdottir E, Olafsdottir E et al. Influence of dietary cod liver oil on fatty acid composition of plasma lipids in human male subjects after myocardial infarction. J Intern.Med. 1990;228:563-8.
  8. Schmidt EB, Pedersen JO, Ekelund S, Grunnet N, Jersild C, Dyerberg J. Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 1989;77:53-7.
  9. Shimokawa H, Vanhoutte PM. Dietary cod liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988;78:1421-30.
  10. Shimokawa H, Lam JY, Chesebro JH, Bowie EJ, Vanhoutte PM. Effects of dietary supplementation with cod liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation 1987;76:898-905.
  11. Burchard HU, Tischendorf FW. The effects of the intake of cod liver oil on the blood lipid level, the lipoprotein profile and bleeding time. Z.Ernahrungswiss. 1989;28:84-91.
  12. Gudbjarnason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern.Med.Suppl 1989;225:117-28.
  13. Gudbjarnason S, Benediktsdottir VE, Skuladottir G. Effects of n-3 polyunsaturated fatty acids on coronary heart disease. Bibl.Nutr Dieta 1989;1-12.
  14. Gudbjarnason S, Oskarsdottir G. Modification of fatty acid composition of rat heart lipids by feeding cod liver oil. Biochim.Biophys.Acta 1977;487:10-5.
  15. Benediktsdottir VE, Gudbjarnason S. Modification of the fatty acid composition of rat heart sarcolemma with dietary cod liver oil, corn oil or butter. J Mol.Cell Cardiol. 1988;20:141-7.
  16. Akpede GO, Omotara BA, Ambe JP. Rickets and deprivation: a Nigerian study. J R.Soc.Health 1999;119:216-22.
  17. Wilton P. Cod liver oil, vitamin D and the fight against rickets. CMAJ. 1995;152:1516-7.
  18. Requirand P, Gibert P, Tramini P, Cristol JP, Descomps B. Serum fatty acid imbalance in bone loss: example with periodontal disease. Clin Nutr 2000;19:271-6.
  19. Watkins BA, Lippman HE, Le Bouteiller L, Li Y, Seifert MF. Bioactive fatty acids: role in bone biology and bone cell function. Prog.Lipid Res. 2001;40:125-48.
  20. Sigurdsson G, Franzson L, Steingrimsdottir L, Sigvaldason H. The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old Icelandic women. Osteoporos.Int. 2000;11:1031-5.
  21. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000;43:1093-8.
  22. Seip M. [Infant nutrition in Norway in the light of recent research]. Tidsskr.Nor Laegeforen. 1991;111:2122-5.
  23. Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T. Effect of cod liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev.Ind.Pharm. 1998;24:757-62.
  24. Olafsdottir AS, Wagner KH, Thorsdottir I, Elmadfa I. Fat-Soluble Vitamins in the Maternal Diet, Influence of Cod liver oil Supplementation and Impact of the Maternal Diet on Human Milk Composition. Ann.Nutr Metab 2001;45:265-72.
  25. Semba RD. Vitamin A as "anti-infective" therapy, 1920-1940. J Nutr 1999;129:783-91.
  26. Lombardo YB, Chicco A, D'Alessandro ME, Martinelli M, Soria A, Gutman R. Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim.Biophys.Acta 1996;1299:175-82.
  27. Chicco A, D'Alessandro ME, Karabatas L, Gutman R, Lombardo YB. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats. Ann.Nutr Metab 1996;40:61-70.
  28. Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M, Shimomura Y. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Diabetes Res.Clin Pract. 1995;28:35-40.
  29. Jensen T, Stender S, Goldstein K, Holmer G, Deckert T. Partial normalization by dietary cod liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N.Engl.J Med. 1989;321:1572-7.
  30. Schimke E, Hildebrandt R, Beitz J et al. Influence of a cod liver oil diet in diabetics type I on fatty acid patterns and platelet aggregation. Biomed.Biochim.Acta 1984;43:S351-S353.
  31. Beitz J, Schimke E, Liebaug U et al. Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxane. Klin.Wochenschr. 1986;64:793-9.
  32. Codde JP, McGowan HM, Vandongen R, Beilin LJ. Changes in prostanoid synthesis in response to diet and hypertension in one-kidney, one clip rats. Hypertension 1985;7:886-92.
  33. Codde JP, Beilin LJ. Dietary fish oil prevents dexamethasone induced hypertension in the rat. Clin Sci.(Lond) 1985;69:691-9.
  34. Moritz V, Singer P, Forster D, Berger I, Massow S. Changes of blood pressure in spontaneously hypertensive rats dependent on the quantity and quality of fat intake. Biomed.Biochim.Acta 1985;44:1491-505.
  35. Singer P, Berger I, Gerhard U, Wirth M, Moritz V, Forster D. Changes of N-6 and N-3 fatty acids in spontaneously hypertensive (SHR) and normotensive rats after diets supplemented with alpha-linolenic or eicosapentaenoic acids. Prostaglandins Leukot.Med. 1987;28:183-93.
  36. Mancino M, Ohia E, Kulkarni P. A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbits. Prostaglandins Leukot.Essent.Fatty Acids 1992;45:239-43.
  37. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990;31:539-44.
  38. Guarner F, Vilaseca J, Malagelada JR. Dietary manipulation in experimental inflammatory bowel disease. Agents Actions 1992;Spec No:C10-C14.
  39. Terkelsen LH, Eskild-Jensen A, Kjeldsen H, Barker JH, Hjortdal VE. Topical application of cod liver oil ointment accelerates wound healing: an experimental study in wounds in the ears of hairless mice. Scand.J Plast.Reconstr.Surg.Hand Surg. 2000;34:15-20.
  40. Eriksen W, Sandvik L, Bruusgaard D. Does dietary supplementation of cod liver oil mitigate musculoskeletal pain? Eur.J Clin Nutr 1996;50:689-93.
  41. Lips P. Vitamin D deficiency in a multicultural setting. Ned.Tijdschr.Geneeskd. 2001;145:2060-2.
  42. Simonsen T, Nordoy A, Sjunneskog C, Lyngmo V. The effect of cod liver oil in two populations with low and high intake of dietary fish. Acta Med.Scand. 1988;223:491-8.
  43. Simonsen T, Nordoy A. Ischaemic heart disease, serum lipids and platelets in Norwegian populations with traditionally low or high fish consumption. J Intern.Med.Suppl 1989;225:83-9.
  44. Luley C, Klein B, Hanisch M, Prellwitz W. Fatty acid composition and degree of peroxidation in fish oil and cod liver oil preparations.Arzneimittel-forschung. 1988;38:1783-6.
  45. Bjerve KS. n-3 fatty acid deficiency in man. J Intern.Med.Suppl 1989;225:171-5.
  46. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N.Engl.J Med. 1995;333:1369-73.
  47. Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358-88.
  48. Die-Smulders CE, Sturkenboom MC, Veraart J, van Katwijk C, Sastrowijoto P, van der LE. Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy. Teratology 1995;52:215-9.
  49. Mills CM, Marks R. Adverse reactions to oral retinoids. An update. Drug Saf 1993;9:280-90.
  50. Heckel S, Favre R, Weber P, Dellenbach P. [Teratogenicity of retinoids. A case and review of the literature]. J Gynecol.Obstet.Biol.Reprod.(Paris) 1993;22:43-7.
  51. Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol. 1993;6 Suppl 1:35-44.
  52. Pinnock CB, Alderman CP. The potential for teratogenicity of vitamin A and its congeners. Med.J Aust. 1992;157:804-9.
  53. Miller RK, Hendrickx AG, Mills JL, Hummler H, Wiegand UW. Periconceptional vitamin A use: how much is teratogenic? Reprod.Toxicol. 1998;12:75-88.
  54. Wiegand UW, Hartmann S, Hummler H. Safety of vitamin A: recent results. Int.J Vitam.Nutr Res. 1998;68:411-6.
  55. Knapp HR and others. The Effect of Cod liver oil on the Development of Atherosclerosis in an Animal Model. Proceedings of the AOCS, Ed WEM Lands, AOCS 1987, pp 35-40.
  56. http://www.animalrights.net/print/articles/2002/000068.html
  57. Shu XO and others. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988 Aug 1;62(3):635-44.
  58. Veierod MG, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 1997 Dec;6(6):540-9.
Seznam literatury k účinkům esenciálních mastných kyselin
  1. Aviram M, Brox J, Nordoy A. Acute effects of dietary cod liver oil and cream on plasma lipoproteins. Ann.Nutr Metab 1986;30:143-8.
  2. Brox JH, Killie JE, Gunnes S, Nordoy A. The effect of cod liver oil and corn oil on platelets and vessel wall in man. Thromb.Haemost. 1981;46:604-11.
  3. Brox JH, Killie JE, Osterud B, Holme S, Nordoy A. Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type IIa). Acta Med.Scand. 1983;213:137-44.
  4. Vognild E, Elvevoll EO, Brox J et al. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. Lipids 1998;33:427-36.
  5. Aviram M, Brox J, Nordoy A. Effects of postprandial plasma and chylomicrons on endothelial cells. Differences between dietary cream and cod liver oil. Acta Med.Scand. 1986;219:341-8.
  6. Brox J, Olaussen K, Osterud B et al. A long-term seal- and cod liver oil supplementation in hypercholesterolemic subjects. Lipids 2001;36:7-13.
  7. Skuladottir GV, Gudmundsdottir E, Olafsdottir E et al. Influence of dietary cod liver oil on fatty acid composition of plasma lipids in human male subjects after myocardial infarction. J Intern.Med. 1990;228:563-8.
  8. Schmidt EB, Pedersen JO, Ekelund S, Grunnet N, Jersild C, Dyerberg J. Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 1989;77:53-7.
  9. Shimokawa H, Vanhoutte PM. Dietary cod liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988;78:1421-30.
  10. Shimokawa H, Lam JY, Chesebro JH, Bowie EJ, Vanhoutte PM. Effects of dietary supplementation with cod liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation 1987;76:898-905.
  11. Burchard HU, Tischendorf FW. The effects of the intake of cod liver oil on the blood lipid level, the lipoprotein profile and bleeding time. Z.Ernahrungswiss. 1989;28:84-91.
  12. Gudbjarnason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern.Med.Suppl 1989;225:117-28.
  13. Gudbjarnason S, Benediktsdottir VE, Skuladottir G. Effects of n-3 polyunsaturated fatty acids on coronary heart disease. Bibl.Nutr Dieta 1989;1-12.
  14. Gudbjarnason S, Oskarsdottir G. Modification of fatty acid composition of rat heart lipids by feeding cod liver oil. Biochim.Biophys.Acta 1977;487:10-5.
  15. Benediktsdottir VE, Gudbjarnason S. Modification of the fatty acid composition of rat heart sarcolemma with dietary cod liver oil, corn oil or butter. J Mol.Cell Cardiol. 1988;20:141-7.
  16. Akpede GO, Omotara BA, Ambe JP. Rickets and deprivation: a Nigerian study. J R.Soc.Health 1999;119:216-22.
  17. Wilton P. Cod liver oil, vitamin D and the fight against rickets. CMAJ. 1995;152:1516-7.
  18. Requirand P, Gibert P, Tramini P, Cristol JP, Descomps B. Serum fatty acid imbalance in bone loss: example with periodontal disease. Clin Nutr 2000;19:271-6.
  19. Watkins BA, Lippman HE, Le Bouteiller L, Li Y, Seifert MF. Bioactive fatty acids: role in bone biology and bone cell function. Prog.Lipid Res. 2001;40:125-48.
  20. Sigurdsson G, Franzson L, Steingrimsdottir L, Sigvaldason H. The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old Icelandic women. Osteoporos.Int. 2000;11:1031-5.
  21. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000;43:1093-8.
  22. Seip M. [Infant nutrition in Norway in the light of recent research]. Tidsskr.Nor Laegeforen. 1991;111:2122-5.
  23. Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T. Effect of cod liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev.Ind.Pharm. 1998;24:757-62.
  24. Olafsdottir AS, Wagner KH, Thorsdottir I, Elmadfa I. Fat-Soluble Vitamins in the Maternal Diet, Influence of Cod liver oil Supplementation and Impact of the Maternal Diet on Human Milk Composition. Ann.Nutr Metab 2001;45:265-72.
  25. Semba RD. Vitamin A as "anti-infective" therapy, 1920-1940. J Nutr 1999;129:783-91.
  26. Lombardo YB, Chicco A, D'Alessandro ME, Martinelli M, Soria A, Gutman R. Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim.Biophys.Acta 1996;1299:175-82.
  27. Chicco A, D'Alessandro ME, Karabatas L, Gutman R, Lombardo YB. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats. Ann.Nutr Metab 1996;40:61-70.
  28. Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M, Shimomura Y. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Diabetes Res.Clin Pract. 1995;28:35-40.
  29. Jensen T, Stender S, Goldstein K, Holmer G, Deckert T. Partial normalization by dietary cod liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N.Engl.J Med. 1989;321:1572-7.
  30. Schimke E, Hildebrandt R, Beitz J et al. Influence of a cod liver oil diet in diabetics type I on fatty acid patterns and platelet aggregation. Biomed.Biochim.Acta 1984;43:S351-S353.
  31. Beitz J, Schimke E, Liebaug U et al. Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxane. Klin.Wochenschr. 1986;64:793-9.
  32. Codde JP, McGowan HM, Vandongen R, Beilin LJ. Changes in prostanoid synthesis in response to diet and hypertension in one-kidney, one clip rats. Hypertension 1985;7:886-92.
  33. Codde JP, Beilin LJ. Dietary fish oil prevents dexamethasone induced hypertension in the rat. Clin Sci.(Lond) 1985;69:691-9.
  34. Moritz V, Singer P, Forster D, Berger I, Massow S. Changes of blood pressure in spontaneously hypertensive rats dependent on the quantity and quality of fat intake. Biomed.Biochim.Acta 1985;44:1491-505.
  35. Singer P, Berger I, Gerhard U, Wirth M, Moritz V, Forster D. Changes of N-6 and N-3 fatty acids in spontaneously hypertensive (SHR) and normotensive rats after diets supplemented with alpha-linolenic or eicosapentaenoic acids. Prostaglandins Leukot.Med. 1987;28:183-93.
  36. Mancino M, Ohia E, Kulkarni P. A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbits. Prostaglandins Leukot.Essent.Fatty Acids 1992;45:239-43.
  37. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990;31:539-44.
  38. Guarner F, Vilaseca J, Malagelada JR. Dietary manipulation in experimental inflammatory bowel disease. Agents Actions 1992;Spec No:C10-C14.
  39. Terkelsen LH, Eskild-Jensen A, Kjeldsen H, Barker JH, Hjortdal VE. Topical application of cod liver oil ointment accelerates wound healing: an experimental study in wounds in the ears of hairless mice. Scand.J Plast.Reconstr.Surg.Hand Surg. 2000;34:15-20.
  40. Eriksen W, Sandvik L, Bruusgaard D. Does dietary supplementation of cod liver oil mitigate musculoskeletal pain? Eur.J Clin Nutr 1996;50:689-93.
  41. Lips P. Vitamin D deficiency in a multicultural setting. Ned.Tijdschr.Geneeskd. 2001;145:2060-2.
  42. Simonsen T, Nordoy A, Sjunneskog C, Lyngmo V. The effect of cod liver oil in two populations with low and high intake of dietary fish. Acta Med.Scand. 1988;223:491-8.
  43. Simonsen T, Nordoy A. Ischaemic heart disease, serum lipids and platelets in Norwegian populations with traditionally low or high fish consumption. J Intern.Med.Suppl 1989;225:83-9.
  44. Luley C, Klein B, Hanisch M, Prellwitz W. Fatty acid composition and degree of peroxidation in fish oil and cod liver oil preparations.Arzneimittel-forschung. 1988;38:1783-6.
  45. Bjerve KS. n-3 fatty acid deficiency in man. J Intern.Med.Suppl 1989;225:171-5.
  46. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N.Engl.J Med. 1995;333:1369-73.
  47. Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358-88.
  48. Die-Smulders CE, Sturkenboom MC, Veraart J, van Katwijk C, Sastrowijoto P, van der LE. Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy. Teratology 1995;52:215-9.
  49. Mills CM, Marks R. Adverse reactions to oral retinoids. An update. Drug Saf 1993;9:280-90.
  50. Heckel S, Favre R, Weber P, Dellenbach P. [Teratogenicity of retinoids. A case and review of the literature]. J Gynecol.Obstet.Biol.Reprod.(Paris) 1993;22:43-7.
  51. Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol. 1993;6 Suppl 1:35-44.
  52. Pinnock CB, Alderman CP. The potential for teratogenicity of vitamin A and its congeners. Med.J Aust. 1992;157:804-9.
  53. Miller RK, Hendrickx AG, Mills JL, Hummler H, Wiegand UW. Periconceptional vitamin A use: how much is teratogenic? Reprod.Toxicol. 1998;12:75-88.
  54. Wiegand UW, Hartmann S, Hummler H. Safety of vitamin A: recent results. Int.J Vitam.Nutr Res. 1998;68:411-6.
  55. Knapp HR and others. The Effect of Cod liver oil on the Development of Atherosclerosis in an Animal Model. Proceedings of the AOCS, Ed WEM Lands, AOCS 1987, pp 35-40.
  56. http://www.animalrights.net/print/articles/2002/000068.html
  57. Shu XO and others. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988 Aug 1;62(3):635-44.
  58. Veierod MG, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 1997 Dec;6(6):540-9.
  59. Pandian SS et al Fatty acids and prostate cancer: current status and future challenges. J R Coll Surg Edinb 1999 Dec;44:352-61.
  60. Myers CE (ed) Prostate Forum, Volume 5, Number 2. February 2000.
  61. Anderson SO et al Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 1996;68:716-22.
  62. Godley PA et al. Biomarkers of Essential Fatty Acid Consumption and Risk of Prostatic Carcinoma. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Vol. 5, p. 889-95, November 1996.
  63. Giovannucci E et al. A Prospective Study of Dietary Fat and Risk of Prostate Cancer. Journal of the National Cancer Institute, Vol. 85, No. 19, October 6, 1993, p. 1571 - 1579.
  64. Gann PH et al. Prospective Study of Plasma Fatty Acids and Risk of Prostate Cancer. Journal of the National Cancer Institute, Vol. 86, No. 4, February 16, 1994, p. 281-6.
  65. De Stefani E et al Alpha-linolenic acid and risk of prostate cancer: a case control study in Uruguay. Cancer Epidemiol Biomarkers Prev 2000 Mar;9(3):335-8.
  66. Harvei S et al. Prediagnostic Levels of Fatty Acids in Serum Phospholipids: n-3 and n-6 Fatty Acids and the Risk of Prostate Cancer. International Journal of Cancer, Vol. 71, p. 545-51, 1997.
  67. Newcomer LM et al The association of fatty acids with prostate cancer risk. Prostate 2001 Jun 1;47(4):262-8.
  68. Pandalai PK et al. The Effects of Omega-3 and Omega-6 Fatty Acids on in Vitro Prostate Cancer Growth. Anticancer Research, Vol. 16, p. 815-20, 1996.
  69. Denmark-Wahnefried W et al Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 2002;58:47-52.
  70. Freeman VL et al Prostatic levels of fatty acids and the histopathology of localized prostate cancer. J Urol 2000 Dec;164(6):2168-72.
  71. Bougnoux P n-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 1999 Mar;2(2):121-6.
  72. Yang YJ et al Comparison of fatty acid profiles in the serum of patients with prostatic cancer and benign prostatic hyperplasia. Clin Biochem 1999 Aug;32(6):405-9.
  73. Hughes-Fulford M et al Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis 2001 May;22(5):701-7.
  74. Wynder EL et al Nutrition and prostate cancer: a proposal for dietary intervention. Nutr Cancer 1994;22(1):1-10.
  75. Ghosh J, Myers CE Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A 1998 Oct 27;95(22):13182-7.
  76. Ramon JM et al Dietary fat intake and prostate cancer risk: a case-control study in Spain. Cancer Causes Control 2000 Sep;11(8):677-8.
  77. Begin ME et al Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med 1985 Aug;19(2):177-86.
  78. Cave WT Jr Dietary n-3 (omega-3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J 1991 May;5(8):2160-6.
  79. Motaung E et al Cytotoxicity of combined essential fatty acids on a human prostate cancer cell line. Prostaglandins Leukot Essent Fatty Acids 1999 Nov;61(5):331-7.
  80. du Toit PJ et al The effect of essential fatty acids on growth and urokinase-type plasminogen activator production in human prostate DU-145 cells. Prostaglandins Leukot Essent Fatty Acids 1996 Sep;55(3):173-7.
  81. Cognault S et al Effect of an alpha-linolenic acid-rich diet on rat mammary tumor growth depends on the dietary oxidative status. Nutr Cancer 2000;36(1):33-41.
  82. Klein V et al Low alpha-linolenic acid content of adipose breast tissue is associated with an increased risk of breast cancer. Eur J Cancer 2000 Feb;36(3):335-40.
  83. Wallen MJ et al Androgen receptor gene mutations in hormone-refractory prostate cancer. J Pathol 1999 Dec;189(4):559-63.
  84. Michaud DS et al A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control 2001 Aug;12(6):557-67.
  85. Aronson WJ et al Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology 2001 Aug;58(2):283-8.
  86. Chung BH et al Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis 2001 Aug;22(8):1201-6.
  87. Erasmus U Fats That Heal Fats That Kill. Alive Books, Burnaby, Canada. 1993.
  88. Hui YH (ed) Bailey's Industrial Oil and Fat Products. 5th Edition. John Wiley and Sons, Inc. New York, 1996.
Seznam literatury ke kokosovému oleji
  1. The Effect Of Virgin Coconut Oil Supplementation For Community-Acquired Pneumonia In Children Aged 3 To 60 Months Admitted At The Philippine Children‘s Medical Center: A Single Blinded Randomized Controlled Trial, CHEST, October 29, 2008
  2. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria.
  3. J Med Food. 2007 Jun;10(2):384-7
  4. Antimicrobial Activity of Saturated Fatty Acids and Fatty Amines against Methicillin-Resistant Staphylococcus aureus, Biological & Pharmaceutical Bulletin, Vol. 27 (2004) , No. 9 1321
  5. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol. 2003 May 15;36(1-2):9-17.
  6. Bactericidal effects of fatty acids and monoglycerides on Helicobacter pylori. Int J Antimicrob Agents. 2002 Oct;20(4):258-62.
  7. Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch Virol. 2001;146(4):777-90.
  8. Killing of Gram-positive cocci by fatty acids and monoglycerides. APMIS. 2001 Oct;109(10):670-8.
  9. In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother. 2001 Nov;45(11):3209-12.
  10. In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides. Antimicrob Agents Chemother. 1999 Nov;43(11):2790-2.
  11. Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection. Crit Care Med. 1999 Sep;27(9):1781-6.
  12. In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother. 1998 Sep;42(9):2290-4.
  13. Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother. 1996 Feb;40(2):302-6.
  14. Inactivation of enveloped viruses in human bodily fluids by purified lipids. Ann N Y Acad Sci. 1994 Jun 6;724:457- 64. Review.
  15. Inactivation of visna virus and other enveloped viruses by free fatty acids and monoglycerides. Ann N Y Acad Sci. 1994 Jun 6;724:465-71.
  16. Lauric acid inhibits the maturation of vesicular stomatitis virus. J Gen Virol. 1994 Feb;75 ( Pt 2):353-61.
  17. Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. J Dairy Sci. 2005 Oct; 88(10):3488-95.
  18. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother. 1987 Jan;31(1):27-31.
  19. The effects of fatty acids and their monoesters on the metabolic activity of dental plaque. J Dent Res. 1984 Jan;63(1):2-5.
  20. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids. 2009 Jul;44(7):593-601. Epub 2009 May 13.
  21. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct;27(5):547-52.
  22. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007 Jul;56(7):985-91.
  23. Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation. Clin Biochem. 2004 Sep;37(9):830-5
  24. Comparative Study of Coconut Oil, Soybean Oil, and Hydrogenated Soybean Oil. PJCS. 2004;24
  25. A diet rich in coconut oil reduces diurnal postprandial variations in circulating tissue plasminogen activator antigen and fasting lipoprotein (a) compared with a diet rich in unsaturated fat in women. J. Nutr. 2003;133:3422-3427.
  26. Antibiotic treatment of atherosclerosis. Curr Opin Lipidol. 2003 Dec;14(6):605-14. Coconut Oil: Atherogenic or Not? (What therefore causes Atherosclerosis?). Philippine Journal of Cardiology. 2003 July-Sept; 31(3):97-104.
  27. Chronic infection and coronary artery disease. Cardiol Clin. 2003 Aug;21(3):333-62. Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology. Int J Cardiol. 2003 Jun;89(2-3):273-9.
  28. Effects of dietary medium-chain triacylglycerols on serum lipoproteins and biochemical parameters in healthy men. Biosci Biotechnol Biochem. 2002 Aug;66(8):1713-8
  29. Results of use of metformin and replacement of starch with saturated fat in diets of patients with type 2 diabetes. Endocr Pract. 2002 May-Jun;8(3):177-83.
  30. Secondary prevention of coronary artery disease with antimicrobials: current status and future directions. Am J Cardiovasc Drugs. 2002;2(2):107-18.
  31. Chronic infections and atherosclerosis. J Med Assoc Thai. 2001 Dec;84 Suppl 3:S650-7.
  32. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000 Jul 11;163(1);49-56.
  33. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 2000 Feb;16(1):17-24.
  34. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000 Jan 15;85(2):140-6.
  35. A cross-over study of the effect of a single oral feeding of medium chain triglyceride oil vs. canola oil on post- ingestion plasma triglyceride levels in healthy men. Altern Med Rev 1999 Feb;4(1):23-8.
  36. Inverse association of dietary fat with development of ischemic stroke in men. JAMA 1997 December;278(24):2145-50.
  37. The role of coconut and coconut oil in coronary heart disease in Kerala, south India. Trop Doct. 1997 Oct;27(4):215-7.
  38. Chronic infections and coronary heart disease: is there a link? Lancet, 1997 Aug;350(9075):430-37.
  39. Review: nutritional support for patients with cirrhosis. J Gastroenterol Hepatol. 1997 Apr;12(4):282-6.
  40. Coconut oil consumption and coronary heart disease. Philipp J Intern Med. 1992 May-Jun; 30(3):165-171.
  41. Lipid patterns and dietary habits of healthy subjects living in urban, suburban and rural areas. Ceylon Med J. 1991 Mar;36(1):9-16.
  42. A reevaluation of coconut oil‘s effect on serum cholesterol and atherogenesis. J Philipp Med Assoc. 1989 Jul-Sep; 65(1):144-152.
  43. Coconut oil revisited. J Philipp Med Assoc. 1989 Jul-Sep; 65(1):140-142.
  44. Medium chain triglycerides (MCT) in aging and arteriosclerosis. J Environ Pathol Toxicol Oncol. 1986 Mar-Apr;6(3- 4):115-21.
  45. Medium chain triglycerides (MCT) in aging and arteriosclerosis. J Environ Pathol Toxicol Oncol 1986 Mar-Apr;6(3- 4):115-21.
  46. Medium chain triglycerides (MCT) in aging and arteriosclerosis. J Environ Pathol Toxicol Oncol. 1986 Mar-Apr;6(3- 4):115-21.
  47. Longitudinal analysis of the relationship between blood pressure and migration: the Tokelau Island Migrant Study. Am J Epidemiol. 1985 Aug;122(2):291-301.
  48. Cholesterol, coconuts, and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau island studies. Am J Clin Nutr. 1981 Aug;34(8):1552-61.
  49. The Tokelau Island Migrant Study: serum lipid concentration in two environments. J Chronic Dis. 1981;34(2-3):45- 55.
  50. Chylothorax as a manifestation of rheumatic mitral stenosis: its postoperative management with a diet of medium-chain triglycerides. Chest 1978;73;672-673
  51. Long-term effect of medium-chain triglyceride on hepatic enzymes catalyzing lipogenesis and cholesterogenesis in rats. J Nutr Sci Vitaminol (Tokyo). 1977;23(1):43-51.
  52. Studies on Fatty Acid Composition of Adipose Tissue and Blood Lipids of Polynesians. Am. J. Clin. Nutr. 1969 May; 22(5):594-605.
  53. Effect of a saturated medium-chain triglyceride on serum-lipids in man. Lancet. 1960 May 21;1(7134):1105-8.
  54. Antitumor effect of medium-chain triglyceride and its influence on the self-defense system of the body. Cancer Detect Prev. 1998;22(3):219-24.
  55. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc. 1995 Jun;95(6):693-7.
  56. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr. 1995 Apr;14(2):202-8.
  57. Menhaden, coconut, and corn oils and mammary tumor incidence in BALB/c virgin female mice treated with DMBA. Nutr Cancer. 1993;20(2):99-106.
  58. A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia model. Br J Cancer. 1988 Nov;58(5):580-3.
  59. The influence of dietary medium chain triglycerides on rat mammary tumor development. Lipids 1987 Jun;22(6):455-61.
  60. Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J Natl Cancer Inst. 1984 Mar;72(3):745-50.
  61. Influence of dietary medium-chain triglycerides on the development of N-methylnitrosourea-induced rat mammary tumors. Cancer Res. 1984 Nov;44(11):5023-8.
  62. Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats. Diabetes Metab Res Rev. 2009 Feb;25(2):185-94.
  63. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes. 2009 May;58(5):1237-44. Epub 2009 Feb 17.
  64. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007 Jul;56(7):985-91.
  65. Results of use of metformin and replacement of starch with saturated fat in diets of patients with type 2 diabetes. Endocr Pract. 2002 May-Jun;8(3):177-83.
  66. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes. 1992 May;41(5):641-7.
  67. Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis. 2003 Nov 17;2(1):10.
  68. Effects of medium- and long-chain triglycerides on sleep and thermoregulatory processes in neonates. J Sleep Res. 1998 Mar;7(1):31-9.
  69. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 1998;62(14):1203-15.
  70. Vegetable oil fortified feeds in the nutrition of very low birthweight babies. Indian Pediatr. 1992 Dec;29(12):1519- 27.
  71. Neonatal hypoglycemia. Biol Neonate. 1990;58 Suppl 1:16-21.
  72. Infant feeding formulas using coconut oil and the medium chain triglycerides. J Am Coll Nutr. 1989 Jun;8(3):253-4.
  73. Absorption of individual fatty acids from long chain or medium chain triglycerides in very small infants. Am J Clin Nutr. 1986 May;43(5):745-51.
  74. Chylous-fluid triglycerides and lipoproteins in a patient with chylothorax put on a diet of butter or medium-chain triglyceride [proceeedings]. Arch Int Physiol Biochim. 1980 Feb;88(1):B17-B19.
  75. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395-420.
  76. Chylothorax as a manifestation of rheumatic mitral stenosis: its postoperative management with a diet of medium-chain triglycerides. Chest 1978;73;672-673
  77. Medium-chain triglyceride feeding in premature infants: effects on calcium and magnesium absorption. Pediatrics. 1978 Apr;61(4):537-45.
  78. MCT absorption by preterm infants. Nutr Rev. 1976 Mar;34(3):71-3.
  79. Correction of the malabsorption of the preterm infant with a medium-chain triglyceride formula. J Pediatr. 1975 Mar;86(3):446-50.
  80. Medium-chain triglyceride feeding in premature infants: effects on fat and nitrogen absorption. Pediatrics. 1975 Mar;55(3):359-70.
  81. Correction of the malabsorption of the preterm infant with a medium-chain triglyceride formula. J Pediatr. 1975 Mar;86(3):446-50.
  82. Lactose-free, medium-chain triglyceride formulas in severe malnutrition. Am J Dis Child. 1973 Sep;126(3):330-5.
  83. Effect of medium chain triglyceride on fecal calcium losses in pancreatic insufficiency. Clin Biochem. 1973 Jun;6(2):136-40.
  84. The effect of medium-chain triglyceride on 47 calcium absorption in patients with primary biliary cirrhosis. Gut. 1973 Aug;14(8):653-6.
  85. The effects of medium-chain triglycerides in the short bowel syndrome. Increased glucose and water transport. Am J Dig Dis. 1972 Mar;17(3):233-8.
  86. Absorption of medium-chain triglycerides in animals with pancreatic atrophy. Am J Dig Dis. 1972 Feb;17(2):129- 37.
  87. Medium Chain Triglycerides in Paediatric Practice. Arch Dis Child. 1970 August; 45(242): 445–452.
  88. Coconut oil as a dietary source of fat with special reference to filled milk. Hawaii Med J. 1969 Jul-Aug;28(6):459- 63.
  89. Assessment of Medium-chain Triglyceride Feeding in Infants with Cystic Fibrosis. Arch. Dis. Childh., 1969, 44, 401.
  90. Nutritional properties of medium-chain triglycerides. J Am Oil Chem Soc. 1968 Jan;45(1):19-22.
  91. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009 May;50(5):1109-17. Epub 2008 Nov 19.
  92. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia. 2008 Nov;49 Suppl 8:33-6.
  93. Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Dev Med Child Neurol. 1989 Apr;31(2):152-60.
  94. Medium chain triglyceride diet in the treatment of intractable childhood epilepsy. Arch Dis Child. 1986 Dec;61(12):1168-72.
  95. Early biochemical and EEG correlates of the ketogenic diet in children with atypical absence epilepsy. Pediatr Neural 1985 Mar-Apr;1(2):104-8.
  96. Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology. 1985 Feb;35(2):237-8.
  97. Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium- chain triglyceride diet. Clin Chem. 1982 Apr;28(4 Pt 1):642-5.
  98. Medium chain triglyceride oil ketogenic diets in the treatment of childhood epilepsy. J Hum Nutr. 1978 Apr;32(2):111-6.
  99. Medium-chain triglyceride diet in the treatment of intractable childhood epilepsy. Dev Med Child Neurol. 1978 Apr;20(2):249-50.
  100. Medium-chain triglycerides in a ketogenic diet. Dev Med Child Neurol. 1977 Aug;19(4):535-8.
  101. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res. 1976 May;10(5):536-40.
  102. Ketogenic diet containing medium-chain triglycerides. J Am Diet Assoc. 1973 Mar;62(3):285-90.
  103. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971 Nov;21(11):1097-103.
  104. An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology. 2003;3(1):36-40.
  105. Clinical and metabolic effects of two lipid emulsions on the parenteral nutrition of septic patients. Nutrition. 2002 Feb;18(2):134-8.
  106. Metabolic effects of medium-chain triglycerides in parenteral nutrition after surgery Zhonghua Wai Ke Za Zhi. 2001 Sep;39(9):694-7.
  107. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol Gastrointest Liver Physiol 2000 Mar;278(3):G467-76.
  108. Long chain versus medium chain lipids in patients with ARDS: effects on pulmonary haemodynamics and gas exchange. Intensive Care Med. 1998 Oct;24(10):1029-33.
  109. Medium-chain compared with long-chain triacylglycerol emulsions enhance macrophage response and increase mucosal mass in parenterally fed rats. Am J Clin Nutr. 1998 Jun;67(6):1265-72.
  110. Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain-triglyceride-containing formula. J Am Diet Assoc. 1997 Jun;97(6):605-11.
  111. Nutritional management of the critically ill neurologic patient. Crit Care Clin. 1997 Jan;13(1):39-49.
  112. Efficacy of different triglycerides in total parenteral nutrition for preventing atrophy of the gut in traumatized rats. JPEN J Parenter Enteral Nutr. 1997 Jan-Feb;21(1):21-6.
  113. Parenteral nutrition in the critically ill: use of a medium chain triglyceride emulsion. Intensive Care Med 1993;19(2):89-95.
  114. A comparison of medium-chain and long-chain triglycerides in surgical patients. Ann Surg. 1993 Feb;217(2):175- 84.
  115. Insulinotropic potency of lauric acid: a metabolic rationale for medium chain fatty acids (MCF) in TPN formulation. J Surg Res. 1992 Apr;52(4):328-33.
  116. Long-chain versus medium and long-chain triglyceride-based fat emulsion in parenteral nutrition of severe head trauma patients. Infusionstherapie. 1990 Oct;17(5):246-8.
  117. Comparison of medium and long chain triglyceride metabolism in intensive care patients on parenteral nutrition. Intensive Care Med. 1989;15(4):250-4.
  118. Clinical and experimental effects of medium-chain-triglyceride-based fat emulsions--a review. Clin Nutr. 1989 Oct;8(5):223-35.
  119. Medium chain triglycerides and structured lipids as unique nonglucose energy sources in hyperalimentation. Lipids. 1987 Jun;22(6):421-3.
  120. The metabolic consequences of infusing emulsions containing medium chain triglycerides for parenteral nutrition: a comparative study with conventional lipid. Ann R Coll Surg Engl. 1986 May;68(3):119-21.
  121. Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes Relat Metab Disord. 2003 Jan;27(1):95- 102.
  122. Larger diet-induced thermogenesis and less body fat accumulation in rats fed medium-chain triacylglycerols than in those fed long-chain triacylglycerols. J Nutr Sci Vitaminol (Tokyo). 2002 Dec;48(6):524-9.
  123. Comparison of diet-induced thermogenesis of foods containing medium- versus long-chain triacylglycerols. J Nutr Sci Vitaminol (Tokyo). 2002 Dec;48(6):536-40.
  124. The thermic effect is greater for structured medium- and long-chain triacylglycerols versus long-chain triacylglycerols in healthy young women. Metabolism. 2001 Jan;50(1):125-30.
  125. Swimming endurance capacity of mice is increased by chronic consumption of medium-chain triglycerides. J Nutr. 1995 Mar;125(3):531-9.
  126. Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long- chain triglycerides. Am J Clin Nutr. 1991 May;53(5):1130-3.
  127. Thermogenesis in humans during overfeeding with medium-chain triglycerides. Metabolism. 1989 Jul;38(7):641-8.
  128. Role of brown adipose tissue in thermogenesis induced by overfeeding a diet containing medium chain triglyceride. Lipids. 1987 Jun;22(6):442-4.
  129. Thermic effect of medium-chain and long-chain triglycerides in man. Am J Clin Nutr. 1986 Nov;44(5):630-4.
  130. Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. Am J Clin Nutr. 1982 Apr;35(4):678-82.
  131. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids. 2009; Jul;44(7):593-601; Epub 2009 May 13
  132. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am J Clin Nutr. 2008 Mar;87(3):621-6.
  133. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007 Jul;56(7):985-91.
  134. Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am J Clin Nutr. 2005 Jan;81(1):7- 15.
  135. Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pac J Clin Nutr. 2003;12(2):151-60.
  136. Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int J Obes Relat Metab Disord. 2003 Dec;27(12):1565-71.
  137. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res. 2003 Mar;11(3):395-402.
  138. Consumption of an oil composed of medium chain triacyglycerols, phytosterols, and N-3 fatty acids improves cardiovascular risk profile in overweight women. Metabolism. 2003 Jun;52(6):771-7.
  139. Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes Relat Metab Disord. 2003 Jan;27(1):95- 102.
  140. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr. 2002 Mar;132(3):329-32.
  141. Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord. 2001 Sep;25(9):1393-400.
  142. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr. 2001 Nov;131(11):2853-9.
  143. Effects of medium-chain fatty acids on body composition and protein metabolism in overweight rats. J Physiol Biochem. 2000 Dec;56(4):337-46.
  144. Endogenous fat oxidation during medium chain versus long chain triglyceride feeding in healthy women. Int J Obes Relat Metab Disord. 2000 Sep;24(9):1158-66.
  145. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 1998;62(14):1203-15.
  146. Covert manipulation of the ratio of medium- to long-chain triglycerides in isoenergetically dense diets: effect on food intake in ad libitum feeding men. Int J Obes Relat Metab Disord. 1996 May;20(5):435-44.
  147. The role of oils containing triacylglycerols and medium-chain fatty acids in the dietary treatment of obesity. The effect on resting energy expenditure and serum lipids. Cas Lek Cesk. 1994 Jun 13;133(12):373-5.
  148. Hypocaloric feeding in obese women: metabolic effects of medium-chain triglyceride substitution. Am J Clin Nutr. 1989 Feb;49(2):326-30.
  149. Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat. Am J Clin Nutr. 1983 Jan;37(1):1-4.
  150. Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. Am J Clin Nutr. 1982 Apr;35(4):678-82.
  151. Diet supplemented with MCT oil in the management of childhood diarrhea. Asia Pac J Clin Nutr. 2007;16(2):286- 92.
  152. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol. 2004 Aug;34(1):9-19.
  153. Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann Surg. 2003 Feb;237(2):246-55.
  154. Effects of dietary medium-chain triacylglycerols on serum lipoproteins and biochemical parameters in healthy men. Biosci Biotechnol Biochem. 2002 Aug;66(8):1713-8.
  155. Comparison of the fat elimination between long-chain triglycerides and medium-chain triglycerides in rats with ischemic acute renal failure. Ren. Fail. 2002 Jan;24(1):1-9.
  156. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol Gastrointest Liver Physiol 2000 Mar;278(3):G467-76.
  157. Review of the toxicologic properties of medium-chain triglycerides. Food Chem Toxicol 2000 Jan:38(1):79-98
  158. Prevention of hyperlipidemic acute pancreatitis during pregnancy with medium-chain triglyceride nutritional support. Int J Pancreatol. 1998 Jun;23(3):187-92.
  159. Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain-triglyceride-containing formula. J Am Diet Assoc. 1997 Jun;97(6):605-11.
  160. Review: nutritional support for patients with cirrhosis. J Gastroenterol Hepatol. 1997 Apr;12(4):282-6.
  161. A medium chain triglyceride-based diet in patients with HIV and chronic diarrhea reduces diarrhea and malabsorption: a prospective, controlled trial. Nutrition. 1996 Nov-Dec;12(11-12):766-71.
  162. Protective effect of coconut oil on renal necrosis occurring in rats fed a methyl-deficient diet. Ren. Fail. 1995 Sep; 17 (5):525-37.
  163. Opposite effects of dietary saturated and unsaturated fatty acids on ethanol-pharmacokinetics, triglycerides and carnitines. J Am Coll Nutr. 1994 Aug:13 (4):338-43.
  164. Pityriasis versicolor and sunscreens containing coconut oil. Lancet. 1987 Sep 19;2(8560):685-6.
  165. Coconut: a review of its uses as they relate to the allergic individual. Ann Allergy. 1983 Oct;51(4):472-81.
  166. Oral treatment of carnitine myopathy. Lancet. 1977 Apr 16;1(8016):853.
  167. Carnitine deficiency of skeletal muscle: report of a treated case. Neurology. 1976 Jul;26(7):633-7.
  168. Regression of alcoholic fatty liver in the rat by medium-chain triglycerides. Am J Clin Nut. 25: Feb; 1972, pp. 175- 81.
  169. Medium Chain Triglycerides in Paediatric Practice. Arch Dis Child. 1970 August; 45(242): 445–452.
  170. Antigenotoxicity of Dietary Coconut Oil: Clara Y. Lim-Sylianco, A.P. Guevara, and Sylianco-Wu, Institute of Chemistry College of Science
  171. Baliga, B. P.; Ivy, A. C. 1961. Beverage Preservation. Pasteurization Of Palm Sap (Neera). Journal Of Agricultural And Food Chemistry 9:149
  172. Palm Sap, Pasteurization, Coconut Palm, Date, Vitamin B1, Riboflavin, Specific Gravity, Solid, Sucrose, Invert Sugar, Acid, Ash
  173. Blunt, K. 1918. Vegetable Oils And Their Use In Cooking. Journal of Home Economics 10:23
  174. Vegetable, Oil, Olive Oil, Wesson Oil, Mazola Oil, Lard, Peanut Oil, Oleomargarine, Coconut Oil, Butter, Cottonseed, Oil, Gingerbread borse, B.B., L.J.M. Rao, K. Ramalakmi, B. Raghaven. 2007. chemical composition of volatiles from coconut sap (neera) and effect of processing. food chemistry 101(3): 877-880
  175. Abstract: Volatiles from (i) fresh, (ii) clarified and (iii) fermented coconut sap neera were isolated by a simultaneous distillation and solvent extraction method using a Likens-Nikerson apparatus and subjected to GC-MS analysis for identification of chemical constituents. Twenty-one compounds (5.33 ppm), constituting more than 98% of the volatiles from fresh neera, were characterised. Typical major flavour compounds found in volatiles of fresh neera were ethyl lactate, phenyl ethyl alcohol, ethyl lactate, 3-hydroxy-2-pentanone, farnesol, 2-methyl tetrahydrofuran, and tetradecanone. Clarified neera contained lower quantities of volatiles, in which 13 compounds (1.31 ppm), constituting more than 97%, were identified. However, the typical flavour components retained were ethyl lactate, phenyl ethyl alcohol, 1-hexanol, 2-methyl tetrahydrofuran, 3-hydroxy-2-pentanone and 2-hydroxy-3-pentanone. Fermented neera contained a greater quantity of volatiles, in which 12 compounds (37.4 ppm), representing more than 95% of the volatiles, were characterised. Ethyl lactate, phenyl ethyl alcohol and farnesol were among the seven compounds retained from fresh neera. The astringency and harsh note of the fermented neera could be due to the increased amounts of acids (19.0 mg/l), such as palmitoleic acid and dodecanoic acid, along with higher concentrations of ethyl alcohol and ethyl esters.
  176. Cajori, F. A. 1918. The Utilization Of Some Nuts As Food. Journal of Home Economics 10:304
  177. Nut, Nut Utilization, Protein, Chestnut, Carbohydrate, Nitrogen, Digestibility, Lichi, Coconut, Pecan, Almond, Paste Digestibility, Peanut, Pine, Walnut, Brazil
  178. Chandrasekaran, A.; King, K. W. 1967. Enzymatic Modification Of Extractability Of Protein From Coconuts (Cocos Nucifera). Journal Of Agricultural And Food Chemistry 15:305.
  179. coconut protein
  180. Child, R.; Nathanael, W. R. N. 1950. Changes In The Sugar Composition Of Coconut Water During Maturation And Germination. Journal Science Of Food And Agriculture 1:326
  181. coconut water, coconut, nut, water, sugar
  182. Fuente, F. S.; Manalac, G. C. 1968. Laboratory-Scale Studies On The Preparation Of Coconut Flour From Granulated Coconut. Philippine Journal Of Science 97(1):45
  183. Coconut Flour Fat
  184. Grant, F. W.; Asare, J. 1956. Gold Coast Achimota School And Its Department Of House Craft. Journal Of Home Economics 48:361
  185. African Diet, Coconut
  186. Haldt, H. P. 1958. Coconut... For Baking. Bakers Digest 32(2):64
  187. Coconut, Nut, Unsweetened Coconut
  188. Hannewijk, J.; Haighton, A. J. 1958. Differential Thermal Analysis. Iii. Melting Curves Of Oils And Fats. Journal Of The American Oil Chemists Society 35:457
  189. Differential Thermal Analysis, Cocoa Butter, Melting Oil, Melting, Chocolate, Margarine, Safflower Oil, Sunflower Oil, Corn Oil, Tung Oil, Soybean Oil, Tea Seed Oil, Linseed Oil, Cottonseed Oil, Peanut Oil, Sesame Oil, Olive Oil, Castor Oil, Rapeseed Oil, Whale Oil, Herring Oil, Palm Oil, Coconut Oil, Palm Kernel Oil, Tallow
  190. Horan, F. E. 1965. Contribution Of Non-Animal Proteins And Fats. Soybean Digest 25(11):21
  191. Fat Consumption, Meat, Consumption, Protein, Protein, Soybean, Oil, Lard, Butter, Beef, Fat, Cottonseed, Oil, Coconut Oil, Corn Oil, Peanut Oil
  192. Jokay, L.; Nelson, G. E.; Powell, E. L. 1967. Development Of Edible Amylaceous Coatings For Food. Food Technology 21(8):12(1064)
  193. Milk Analogues, Soybean Milk, Sensory Evaluation, Peanut Milk Protein, Coconut Milk, Nut, Protein, Cheese Analogues, Vegetable-Based Cheese, Mold Fermentation Milk Analogues, Soybean Milk, Sensory Evaluation, Peanut Milk Protein, Coconut Milk, Nut, Protein, Cheese Analogues, Vegetable-Based Cheese, Mold Fermentation
  194. Kajs, T. M.; Hagenmaier, R.; Vanderzant, C.; Mattil, K. F. 1976. Microbiological Evaluation Of Coconut And Coconut Products. Journal Of Food Science 41:352
  195. Coconut, Nut, Bacteria
  196. Koman, V.; Kotuc, J. 1976. Computer Determination Of Chemical And Physical Values Of Fats And Oils From Glc Fatty Acid Composition, Acid Value, And Titer. Journal Of The American Oil Chemists Society 53:563
  197. coconut oil fatty acid, coconut oil iodine value, coconut oil hydrogenation, coconut oil saponification value, peanut oil fatty acid, coconut oil acid number, coconut oil titer, peanut oil iodine value, peanut oil hydrogenation, peanut oil saponification value, peanut oil acid number, peanut oil titer, sunflower oil fatty acid, sunflower oil iodine value, sunflower oil hydrogenation, sunflower oil saponification value, sunflower oil acid number, sunflower oil titer, linseed oil fatty acid, linseed oil iodine value, linseed oil hydrogenation, linseed oil saponification value, linseed oil acid number, linseed oil titer, rapeseed oil fatty acid, rapeseed oil iodine value, rapeseed oil hydrogenation, rapeseed oil saponification value, rapeseed oil acid number, rapeseed oil titer, lard fatty acid, lard iodine value, lard hydrogenation, lard saponification value, lard acid number, lard titer
  198. Lachance, P. A.; Molina, M. R. 1974. Nutritive Value Of A Fiber-Free Coconut Protein Extract Obtained By An Enzymic-Chemical Method. Journal Of Food Science 39:581
  199. Coconut, Protein
  200. Large, J. I. 1911. On The Dietary In Use In The South Pacific Islands Journal Of Home Economics 3:90
  201. Food Habit, Dietary Survey, South Pacific Diet, Kumara, Taro, Ui, Yam, Papaw Apple, Kuru, Tomato, Pumpkin, Squash, Fish, Fish, Mangaa Fish, Fish, Fish, Groper Fish, Turtle, Cubiu Bread, Biscuit, Coconut, Water
  202. Lin, F. M.; Wilkins, W. F. 1970. Volatile Flavor Components Of Coconut Meat. Journal Of Food Science 35:538
  203. Coconut Meat, Flavor
  204. Lopez, H.; Navia, J. M.; Clement, D.; Harris, R. S. 1963. Nutrient Composition Of Cuban Foods. Iii. Foods Of Vegetable Origin. Journal Of Food Science 28:600
  205. Cuban , Asiatic Lotus, Garlic, Turnip, Akee, Pear, Maya, Allspice, Amaranth, Fruiting Spike, , Cauliflower, Justicia, Manioc Shoots, Mint, Purslane, Cabbage, Squash, Sweet Potato, Tea Weed, Adzuki Bean, Cashew Nut, Corojo, Macadamia Nut, Pea, Royal Palm Fruit, Squash Seed, , Cherry, Bignay, Governor‘s Palm, Litchi, Potato, Corn, Carrot, Garlic, Malanga, Pepper, Plantain, Tomato, Chard, Leek, Lettuce, Parsley, Watercress, Moisture, Fiber, Nitrogen, Ash, Calcium, Phosphorus, Iron, Carotene, Thiamin, Riboflavin, Niacin, Ascorbic Acid, Tryptophan, Methionine, Lysine, Legume, Oilseed, Coconut, Guava, Sweet Lime, Peanut, Cowpea, Grapefruit, Myrobalan, Papaya
  206. Mccandlish, A. C.; Weaver, E. 1922. Coconut Meal, Gluten Feed, Peanut Meal And Soybean Meal As Protein Supplements For Dairy Cows. Journal Of Dairy Science 5:27
  207. Protein Supplement, Coconut Meal, Gluten Feed, Peanut Meal, Soybean Meal, Dairy Cow
  208. Narayan, R.; Swaminathan, M.; Sreenivasan, A.; Subrahmanyan, V. 1963. Development And Evaluation Of Processed Foods Based On Legumes, Oil Seeds, Oil Seed Meals And Protein Isolates Thereof. Qualitas Plantarum Et Material Vegetabiles 10:133
  209. protein, fat, tryptophan, threonine, calorie, vitamin D, nicotinic acid, carbohydrate, lysine, methionine + cystine, calcium, valine, phosphorus, iron, thiamin, riboflavin, nicotinic acid, vitamin A, coconut Soybean, Peanut, Cottonseed, Sesame, Copra, Sunflower, Chickpea, Legume, Peanut Flour, Soybean Flour, coconut meal, Chickpea Flour, Cottonseed Flour, Sesame Meal, Infant Formula Mineral, Spray Dried Milk, Slim Milk Powder, Tapioca Macaroni, Multipurpose Food, Malt, Diet
  210. Narayana Rao, M.; Dwarakanath, C. T.; Ramachandra Rao, T. N. 1968. Development Of Pre-Digested Protein-Rich Food Based On Indian Oil Seed Cakes And Pulses Part I. Journal Of Food Science And Technology 5:198.
  211. Oilseed Cake, Pulse, Soybean, Coconut, Miso Ph, Miso Nitrogen, Miso Reducing Sugar, Miso Nitrogen, Miso Lactic Acid, Miso Lysine, Miso Methionine, Miso Tryptophan
  212. Peamprasart, T., N. Chiewchan. 2006. Effect of fat content and preheat treatment on the apparent viscosity of coconut milk after homogenization. Journal of Food Engineering 77(3): 653-658.
  213. Abstract: This research aimed to study the effect of fat content (15-30%) and preheat temperature (70-90 °C) on the apparent viscosity of coconut milk after homogenization. By using a power-law model, all samples exhibited pseudoplastic behavior with the flow behavior index (n) between 0.713 and 0.930. Overall, the results showed that preheat treatment had a significant effect on the apparent viscosity of coconut milk. At similar fat concentration, an increase in viscosity was observed at higher preheat temperatures. This phenomenon was more pronounced in the samples with increasing fat content. The microscopic study showed that smaller aggregates of fat globules were detected for the sample passing higher heating temperature. The presence of small aggregates hence increased the resistance to flow leading to an increase in the viscosity of the homogenized heat-treated coconut milk.
  214. Rajasekharan, N. 1967. The Use Of Coconut Preparations As A Protein Supplement In Child Feeding. Journal Of Food Science And Technology 4:59
  215. Coconut, Moisture, Coconut Shell, Coconut Kernel, Coconut, Water, Coconut Cake, Copra, Coconut, Protein, Coconut, Fat, Coconut, Fiber, Coconut, Carbohydrate, Coconut, Ash, Coconut Oil, Protein Efficiency Ratio, Infant Food, Cereal, Protein , Coconut, Amino Acid
  216. Rama Rao, G.; Indira, K.; Bhima Rao, U. S.; Ramaswamy, K. G. 1964. Protein Efficiency Ratio Of Coconut Flour And Some Products From It Produced By Azeotropic Process. Journal Of Food Science And Technology 1(2):23
  217. Azeotropic Process, Protein Efficiency Ratio, Coconut Flour, Coconut Flake, Coconut Meal, Coconut Protein Concentrate, Rat Growth, Coconut, Moisture, Coconut, Ash, Coconut, Fiber, Coconut, Carbohydrate
  218. Rao, S. V.; Daniel, V. A.; Leela, R.; Hariharan, K.; Swaminathan, M.; Parpia, H. A. 1964. Mutual And Amino Acid Supplementation Of Proteins. I. Effect Of Supplementation Of Blends Of Ground Nut, Soya Bean, Sesame And Coconut With The Limiting Amino Acids On The Nutritive Value Of The Proteins. Journal Of Nutrition. Dietetics 1:184
  219. Amino Acid Supplementation, Groundnut Flour, Lysine Supplementation, Ground Nut Flour, Methionine Supplementation, Threonine Supplementation, Protein Efficiency Ratio, Soybean Flour, Sesame Flour, Coconut Meal
  220. Rice, F. E. 1960. Review Of Filled Milk, Nutritional Evaluation Of The Replacment Of The Fat In Whole Cow‘s Milk By Coconut Oil. Journal Of Agricultural And Food Chemistry 8:488
  221. Filled Milk, Coconut Oil, Coconut Milk, Oil
  222. Rodrigues, S., G.A.S. Pinto. 2007June. Ultrasound extraction of phenolic compounds from coconut (Cocos nucifera) shell powder. journal of Food Engineering 80(3): 869-872
  223. Abstract: Coconut is a tropical fruit largely consumed in many countries. In some areas of the Brazilian coast, coconut shell represents more than 60% of the domestic waste volume. The shell is composed mainly of lignin and cellulose with chemical composition very similar to wood. As several kinds of wood are used as a phenolic source to produce extracts for artificial aging of alcoholic beverages, in this work, the coconut shell was evaluated as a source of phenolic compounds. The coconut powder was submitted to different toasting temperatures and the phenolic compounds were extracted by the application of ultrasound. The ultrasound extraction methodology has been studied as a low cost alternative in substitution to solvent reflux extraction. The experiments were done according to a factorial experimental planning and the effects of toasting time, toasting temperature and extraction time were evaluated through response surface methodology. The results indicate that high amounts of phenolics can be extracted from coconut shell by ultrasound assisted extraction technology, and that the extraction time was the most significant parameter for the process.
  224. Rody, N. 1978. Things Go Better With Coconuts - Program Strategies In Micronesia. Journal Of Nutrition Education 10(1):19
  225. Micronesia, Coconut, Nutrition Education, Soft Drink, Food Behavior
  226. Siahaan, D., O.M. del Rosario, R.R. del Rosario, O.M. del-Rosario, R.R. del-Rosario. 2001. Fractional crystallization of coconut oil in acetone. Philippine Agricultural Scientist 84: 4, 375-381.
  227. Low-temperature solvent fractional crystallization was employed to enrich long-chain saturated fatty acids (LCSFA) and medium-chain fatty acids (MCFA) or unsaturated fatty acids (UFA) in coconut oil (CNO), and to optimize conditions for increased yield of high melting-point solid fractions (coco-stearin). Tests showed that acetone was the most suitable solvent. The optimum conditions for crystallization were 10°C for 6 h in an acetone-CNO ratio of 2:1. By single-step fractionation (SSF) coco-stearin was enriched by 4.6%, while by multiple- step fractionation (MSF) coco-stearin III was enriched by 4.4%. By SSF, UFA was enriched in olein by 13.6%, in olein II by 15.6%, and in CNO by 10.8%. The yield of coco-stearin in SSF was 28.3% and in MSF 21.7%.
  228. Tasker, P. K.; Narayanarao, M.; Swaminathan, M.; Sankaran, A. N.; Jayaraj, A. P.; Subrahmanyan, V. 1961. Dietary Supplements, The Supplementary Value Of A Low-Cost Protein Based On A Blend Of Peanut, Coconut, And Chickpea (Cicerarietinum) Flours To A Maize-Tapioca Diet. Journal Of Agricultural And Food Chemistry 9:413
  229. Dietary Supplement, Protein Supplement, Corn-Tapioca Diet, Peanut Flour, Coconut Flour, Chickpea Flour
  230. Vail, G. E.; Hilton, R. 1943. Edible Fats And Oils. Two Chemical Characteristics. Journal Of Home Economics 35:43
  231. Fat, Oil, Soybean Oil, Smoke Point, Oleic Acid, Free Fatty Acid, Primex, Snow Drift, Wesson Oil, Puritan Oil, Spry, Coconut Oil, Crisco, Lard, Leaf Lard, Armour Star Lard, Mazola Oil, Penick Oil, Covo, Dexo, Kneedit, Flakewhite, Peanut Oil, Peanut Oil, Vegetol
  232. Waisundara, V.Y., C.O. Perera, P.J. Barlow. 2007. Effect of different pre-treatments of fresh coconut kernels on some of the quality attributes of the coconut milk extracted. Food Chemistry 101(2): 771-777.
  233. Abstract: Fresh, dehusked and shelled coconut kernels were subjected to blanching and freezing treatments and were tested for chemical and enzymatic deterioration and yield of milk by monitoring the percentage extraction of coconut milk, free fatty acid (FFA) content, peroxide value (PV), lipase (LIP) and peroxidase (POD) activities, once each fortnight for a total period of 8 weeks. The percentage extraction of milk varied between 31.0% and 33.5% in the blanched samples and did not show a significant change at p > 0.05, as compared to the values at week 0. Similar observations were seen in FFA content and the PV. The LIP activity in these samples decreased to almost 0.176% liberated FFA and POD activity to 0.387 Absorbance Units/g fresh-weight. In conclusion, the results indicated the efficiency of the pre-treatment in suppressing the chemical and enzymatic deterioration of coconut kernels, which normally results in the loss of quality of the coconut milk when extracted.
(C) Upnet Multimedia 2008